A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines

An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine

NCT01686581 ·Status: COMPLETED

Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches

NCT00660192 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Use of a Treatment Benefit Questionnaire in Patients With Chronic Migraine Treated With OnabotulinumtoxinA (BOTOX®)

NCT01833130 ·Status: COMPLETED ·Phase: PHASE4

OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study

NCT01920945 ·Status: TERMINATED ·Phase: PHASE2

A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine

NCT01662492 ·Status: COMPLETED ·Phase: PHASE3

Tandem OnabotulinumtoxinA Galcanezumab Emerging Therapeutic Headache Elimination Research Study

NCT05492695 ·Status: TERMINATED ·Phase: PHASE4

BOTOX® Prophylaxis in Patients With Chronic Migraine

NCT01432379 ·Status: COMPLETED

A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches

NCT00168428 ·Status: COMPLETED ·Phase: PHASE3

OnabotulinumtoxinA Injections in Chronic Migraine, Targeted to Sites of Pericranial Myofascial Pain

NCT03175263 ·Status: COMPLETED

Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine

NCT05216263 ·Status: COMPLETED ·Phase: PHASE3

Onabotulinum Dose Comparison in Chronic Migraine Superior to 100 Units?

NCT04349176 ·Status: TERMINATED ·Phase: PHASE3

BOTOX® vs. XEOMIN® for Chronic Migraine

NCT05598723 ·Status: RECRUITING ·Phase: PHASE3

Efficacy of OnabotulinumtoxinA in Migraine

NCT04578782 ·Status: COMPLETED ·Phase: PHASE2

Open Label Study of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic Migraine

NCT03193359 ·Status: WITHDRAWN ·Phase: PHASE3

Sustained onabotulinumtoxinA Therapeutic Benefits in Patients With Chronic Migraine

NCT03606356 ·Status: COMPLETED ·Phase: PHASE4

Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine

NCT04069897 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Botox Injection in Treatment of Chronic Migraine

NCT02259075 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Calcitonin Gene-related Peptide Levels in Chronic Migraine

NCT01071096 ·Status: COMPLETED ·Phase: PHASE4

COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study

NCT05724771 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine

NCT05028569 ·Status: TERMINATED ·Phase: PHASE3

(Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist

NCT03381261 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults

NCT02191579 ·Status: COMPLETED ·Phase: PHASE4

Study in Participants With Acute Migraines Headaches

NCT00804973 ·Status: TERMINATED ·Phase: PHASE2

A Study of LY2951742 in Participants With Migraine

NCT01625988 ·Status: COMPLETED ·Phase: PHASE2

A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches

NCT00156910 ·Status: COMPLETED ·Phase: PHASE3